Cargando…

Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer

INTRODUCTION: Breast cancer (BC) is one of the leading causes of death among women worldwide. Immunostimulatory treatment has increasingly been used as adjuvant therapy in the last few years, in patients with melanoma and other cancer forms, often with an induction of autoimmunity as a consequence o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Einefors, Rickard, Kogler, Ulrika, Ellberg, Carolina, Olsson, Håkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755812/ https://www.ncbi.nlm.nih.gov/pubmed/24010029 http://dx.doi.org/10.1186/2193-1801-2-357

Ejemplares similares

Breast cancer patients with lobular cancer more commonly have a father than a mother diagnosed with cancer
por: Ellberg, Carolina, et al.
Publicado: (2011)

Current smoking is associated with a larger waist circumference and a more androgenic profile in young healthy women from high-risk breast cancer families
por: Ellberg, Carolina, et al.
Publicado: (2018)

Genetic testing in women with early-onset breast cancer: a Traceback pilot study
por: Augustinsson, Annelie, et al.
Publicado: (2021)

ERβ1: characterization, prognosis, and evaluation of treatment strategies in ERα-positive and -negative breast cancer
por: Reese, Jordan M, et al.
Publicado: (2014)

Bioinformatics Identification of TUBB as Potential Prognostic Biomarker for Worse Prognosis in ERα-Positive and Better Prognosis in ERα-Negative Breast Cancer
por: Alhammad, Rashed
Publicado: (2022)

Metabotropic glutamate receptor 1 is associated with unfavorable prognosis in ER-negative and triple-negative breast cancer
por: Bastiaansen, Anna E. M., et al.
Publicado: (2020)

GREM1 is associated with metastasis and predicts poor prognosis in ER-negative breast cancer patients
por: Neckmann, Ulrike, et al.
Publicado: (2019)

Expression of MTDH and IL-10 Is an Independent Predictor of Worse Prognosis in ER-Negative or PR-Negative Breast Cancer Patients
por: Chu, Pei-Yi, et al.
Publicado: (2020)

Targeting estrogen to kill ER-positive and ER-negative breast cancer
por: Jordan, VC
Publicado: (2005)

Autoimmune Mechanisms of Interferon Hypersensitivity and Neurodegenerative Diseases: Down Syndrome
por: Jagadeesh, Ashraya, et al.
Publicado: (2020)

ER Stress Proteins in Autoimmune and Inflammatory Diseases
por: Morito, Daisuke, et al.
Publicado: (2012)

RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer
por: Ciscar, Marina, et al.
Publicado: (2023)

Tamoxifen Action in ER-Negative Breast Cancer
por: Manna, Subrata, et al.
Publicado: (2016)

Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER
por: Girgert, Rainer, et al.
Publicado: (2019)

Molecular Insights Into the Relationship Between Autoimmune Thyroid Diseases and Breast Cancer: A Critical Perspective on Autoimmunity and ER Stress
por: Rahman, Safikur, et al.
Publicado: (2019)

An ER-associated miRNA signature predicts prognosis in ER-positive breast cancer
por: Zhou, Xin, et al.
Publicado: (2014)

A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer
por: Teschendorff, Andrew E, et al.
Publicado: (2008)

CXCL9 Is a Potential Biomarker of Immune Infiltration Associated With Favorable Prognosis in ER-Negative Breast Cancer
por: Liang, Yuan-ke, et al.
Publicado: (2021)

Impact of Pregestational Weight and Weight Gain during Pregnancy on Long-Term Risk for Diseases
por: Moll, Ulrika, et al.
Publicado: (2017)

Apoptosis/Necrosis Induction by Ultraviolet, in ER Positive and ER Negative Breast Cancer Cell Lines
por: Shokrollahi Barough, Mahdieh, et al.
Publicado: (2015)

Immunolocalization of Cytoplasmic ER in ER-negative Breast Carcinoma as a Potent Favorable Prognostic Predictor
por: Ebata, Akiko, et al.
Publicado: (2023)

Autoimmune Hypothyroidism As a Predictor of Mortality in Chronic Hypersensitivity Pneumonitis
por: Adegunsoye, Ayodeji, et al.
Publicado: (2017)

Protein truncating variants in FANCM and risk for ER-negative/triple negative breast cancer
por: Peterlongo, Paolo, et al.
Publicado: (2021)

A major genetic determinant of autoimmune diseases is associated with the presence of autoantibodies in hypersensitivity pneumonitis
por: Buendía-Roldán, Ivette, et al.
Publicado: (2020)

Lung fibrosis in autoimmune diseases and hypersensitivity: how to separate these from idiopathic pulmonary fibrosis
por: Popper, Helmut, et al.
Publicado: (2021)

Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers
por: Groenendijk, Floris H., et al.
Publicado: (2019)

An estrogen receptor (ER)‐related signature in predicting prognosis of ER‐positive breast cancer following endocrine treatment
por: Tang, Jianing, et al.
Publicado: (2019)

Bioactive Dietary Supplements Reactivate ER Expression in ER-Negative Breast Cancer Cells by Active Chromatin Modifications
por: Meeran, Syed M., et al.
Publicado: (2012)

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines
por: Shen, Kui, et al.
Publicado: (2012)

Different Proliferation Patterns in Breast Cancer: AgNOR Measurements in ER-Negative and ER-Positive Tumor Cells
por: Günther, Lukas, et al.
Publicado: (2000)

Weight Loss Intervention in Survivors of ER/PR-negative Breast Cancer
por: Vitolins, Mara Z, et al.
Publicado: (2014)

Prognostic Impact of HOTAIR Expression is Restricted to ER-Negative Breast Cancers
por: Gökmen-Polar, Yesim, et al.
Publicado: (2015)

ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling
por: Hutchinson, Samantha A, et al.
Publicado: (2019)

Targeting the mTOR Pathway for the Prevention of ER-Negative Breast Cancer
por: Mazumdar, Abhijit, et al.
Publicado: (2022)

The Role of Autoimmune Diseases in the Prognosis of Lymphoma
por: Masciopinto, Pierluigi, et al.
Publicado: (2020)

The Effects of a Novel Nanohydroxyapatite Gel and Er: YAG Laser Treatment on Dentin Hypersensitivity
por: Sahin, Demet, et al.
Publicado: (2023)

FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
por: Lv, Qing, et al.
Publicado: (2021)

Women with a predisposition for diabetes have an increased risk of pregnancy complications, especially in combination with pregestational overweight
por: Moll, Ulrika, et al.
Publicado: (2020)

Correction to: Women with a predisposition for diabetes have an increased risk of pregnancy complications, especially in combination with pregestational overweight
por: Moll, Ulrika, et al.
Publicado: (2020)

Diagnosing MRI-negative autoimmune diseases
por: Finke, Carsten
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_meratr4gqq0neu1ilpqlfk7slb